SCHEMBL18624813

SCHEMBL18624813

c1ccc(-c2cccc(-c3cccc(-c4nc(-c5cccc(-c6cccc(-c7cccnc7)c6)c5)nc(-c5cccc(-c6cccc(-c7cccnc7)c6)c5)n4)c3)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.58
CYP11B1 P15538 3/20 0.58
CYP11B2 P19099 3/20 0.58
CYP17A1 P05093 1/20 0.58
KMO O15229 1/20 0.57
CYP2A6 P11509 5/20 0.56
ALDH1A1 P00352 3/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
MKNK1 Q9BUB5 3/20 0.55
MKNK2 Q9HBH9 3/20 0.55
MEN1 O00255 1/20 0.55
PSIP1 O75475 1/20 0.55
AXL P30530 1/20 0.55
SMN1; SMN2 Q16637 4/20 0.50
TP53 P04637 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18327487 1.00 CYP19A1 (0.58) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL18327354 0.96 CYP19A1 (0.59) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL18327447 0.96 CYP19A1 (0.59) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL21982129 0.96 CYP19A1 (0.59) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL19543716 0.96 CYP19A1 (0.59) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL19039944 0.96 CYP19A1 (0.59) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL19238737 0.96 CYP19A1 (0.58) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL17755349 0.96 CYP19A1 (0.58) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL18327328 0.96 CYP19A1 (0.58) CYP19A1CYP11B1CYP11B2CYP17A1KMO
SCHEMBL17720949 0.96 CYP19A1 (0.58) CYP19A1CYP11B1CYP11B2CYP17A1KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11778908-B2 Organic electroluminescent devices KUNSHAN GO-VISIONOX OPTO-ELECTRONICS CO., LTD. (CN) 2023-10-03 US disclosed
US-20170077418-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2017-03-16 US disclosed
US-20170077418-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2017-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170077418-A1 ORGANIC ELECTROLUMINESCENT DEVICE EPCAM, L1CAM, LAGE3 CYP19A1 4370/4885CYP11B1 4210/4885CYP11B2 3739/4885
US-11778908-B2 Organic electroluminescent devices LAGE3, ELAVL3, ILK CYP19A1 4081/4885CYP11B1 4574/4885CYP11B2 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.